.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Teva
QuintilesIMS
Chubb
Healthtrust
Cantor Fitzgerald
Harvard Business School
Covington
Dow
Deloitte

Generated: December 12, 2017

DrugPatentWatch Database Preview

Lederle Company Profile

« Back to Dashboard

What is the competitive landscape for LEDERLE, and what generic and branded alternatives to LEDERLE drugs are available?

LEDERLE has ninety-six approved drugs.



Summary for Lederle

US Patents:0
Tradenames:49
Ingredients:48
NDAs:96
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LederleAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL087370-001Jan 4, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederlePROBENECID W/ COLCHICINEcolchicine; probenecidTABLET;ORAL086954-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleCHLORDIAZEPOXIDE HYDROCHLORIDEchlordiazepoxide hydrochlorideCAPSULE;ORAL087234-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleSULFISOXAZOLEsulfisoxazoleTABLET;ORAL087649-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleVANCOLEDvancomycin hydrochlorideFOR SOLUTION;ORAL063321-002Oct 15, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleAMITRIPTYLINE HYDROCHLORIDEamitriptyline hydrochlorideTABLET;ORAL087181-001Jan 4, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleHALOPERIDOLhaloperidolTABLET;ORAL072731-001Sep 19, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleAUREOMYCINchlortetracycline hydrochlorideOINTMENT;OPHTHALMIC050404-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleARTANEtrihexyphenidyl hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL012947-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Lederle

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
LederleASENDINamoxapineTABLET;ORAL018021-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LederleASENDINamoxapineTABLET;ORAL018021-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for LEDERLE drugs

Drugname Dosage Strength Tradename Submissiondate
cefiximefor Oral Suspension500 mg/5 mLSUPRAX7/22/2014

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Fuji
McKinsey
Baxter
Cipla
Farmers Insurance
Chinese Patent Office
Federal Trade Commission
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot